Efficacy and safety of hyperbaric oxygen therapy for fibromyalgia: a systematic review and meta-analysis
- PMID: 36690401
- PMCID: PMC9872467
- DOI: 10.1136/bmjopen-2022-062322
Efficacy and safety of hyperbaric oxygen therapy for fibromyalgia: a systematic review and meta-analysis
Abstract
Objective: To investigate the efficacy and safety of hyperbaric oxygen therapy (HBOT) for fibromyalgia (FM).
Design: A systematic review and meta-analysis.
Data sources: PubMed, EMBASE, Cochrane Library, Web of Science, VIP (China Science and Technology Journal Database), CNKI (China National Knowledge Infrastructure) and WanFang database were searched from from inception to 22 October 2022.
Eligibility criteria: We included clinical trials (randomised controlled and non-randomised controlled trials) of HBOT for FM.
Data extraction and synthesis: Two researchers independently screened the literature, extracted data and evaluated the quality of the included studies, with disagreements resolved by a third researcher. The Cochrane Collaboration checklists and the Methodological Index for Non-randomised Studies were used to assess the risk of bias. Meta-analysis was performed by RevMan V.5.4.1 software. Random effect models were used for meta-analysis.
Results: Nine studies were included in this review, with a total of 288 patients. For pain assessment, we combined the results of the Visual Analogue Scale and Widespread Pain Index. The results showed that HBOT could relieve the pain of FM patients compared with the control intervention (standardised mean difference=-1.56, 95% CI (-2.18 to -0.93), p<0.001, I 2=51%). Most included studies reported that HBOT ameliorated tender points, fatigue, multidimensional function, patient global and sleep disturbance in FM. Adverse events occurred in 44 of 185 patients (23.8%). Twelve patients (6.5%) withdrew because of adverse reactions. No serious adverse events or complications were observed.
Conclusions: HBOT might have a positive effect in improving pain, tender points, fatigue, multidimensional function, patient global and sleep disturbance in FM, with reversible side effects. Low pressure (less than 2.0 atmospheric absolute) may be beneficial to reduce adverse events in FM. Further studies should be carried out to evaluate the optimal protocol of HBOT in FM.
Prospero registration number: CRD42021282920.
Keywords: PAIN MANAGEMENT; Rehabilitation medicine; Rheumatology.
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures



Similar articles
-
Hyperbaric oxygen therapy for patients with fibromyalgia: a systematic review protocol.BMJ Open. 2023 Jun 14;13(6):e071092. doi: 10.1136/bmjopen-2022-071092. BMJ Open. 2023. PMID: 37316317 Free PMC article.
-
Evaluation of a Hyperbaric Oxygen Therapy Intervention in Individuals with Fibromyalgia.Pain Med. 2021 Jun 4;22(6):1324-1332. doi: 10.1093/pm/pnaa416. Pain Med. 2021. PMID: 33594439 Clinical Trial.
-
Meta-Analysis on the Efficacy and Safety of Hyperbaric Oxygen as Adjunctive Therapy for Vascular Dementia.Front Aging Neurosci. 2019 Apr 17;11:86. doi: 10.3389/fnagi.2019.00086. eCollection 2019. Front Aging Neurosci. 2019. PMID: 31057392 Free PMC article.
-
Hyperbaric oxygen therapy for poststroke insomnia: a systematic review and meta-analysis protocol.BMJ Open. 2024 Mar 29;14(3):e081642. doi: 10.1136/bmjopen-2023-081642. BMJ Open. 2024. PMID: 38553058 Free PMC article.
-
Adjunctive hyperbaric oxygen therapy and negative pressure wound therapy for hard-to-heal wounds: a systematic review and meta-analysis.J Wound Care. 2024 Dec 2;33(12):950-957. doi: 10.12968/jowc.2022.0213. J Wound Care. 2024. PMID: 39630554
Cited by
-
Comparative efficacy of neuromodulation and structured exercise program on pain and muscle oxygenation in fibromyalgia patients: a randomized crossover study.Front Physiol. 2024 Jul 23;15:1414100. doi: 10.3389/fphys.2024.1414100. eCollection 2024. Front Physiol. 2024. PMID: 39108537 Free PMC article.
-
Effects of Hyperbaric Oxygen Therapy on Long COVID: A Systematic Review.Life (Basel). 2024 Mar 26;14(4):438. doi: 10.3390/life14040438. Life (Basel). 2024. PMID: 38672710 Free PMC article. Review.
-
Mild hyperbaric hyperoxia improves aerobic capacity and suppresses cardiopulmonary stress during the maximal cycle-ergometer test.PLoS One. 2025 May 23;20(5):e0323885. doi: 10.1371/journal.pone.0323885. eCollection 2025. PLoS One. 2025. PMID: 40408365 Free PMC article.
-
Guidelines on Treating Fibromyalgia With Nonpharmacological Therapies in China.J Evid Based Med. 2025 Jun;18(2):e70044. doi: 10.1111/jebm.70044. J Evid Based Med. 2025. PMID: 40500865 Free PMC article.
-
Is there a rationale for hyperbaric oxygen therapy in the patients with Post COVID syndrome? : A critical review.Eur Arch Psychiatry Clin Neurosci. 2024 Dec;274(8):1797-1817. doi: 10.1007/s00406-024-01911-y. Epub 2024 Nov 15. Eur Arch Psychiatry Clin Neurosci. 2024. PMID: 39545965 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical